Gabriele Materazzi Selected Research

Gabriele Materazzi Research Topics

Disease

37	Neoplasms (Cancer) 10/2023 - 02/2004
34	Thyroid Neoplasms (Thyroid Cancer) 04/2024 - 04/2010
15	Papillary Thyroid Cancer 10/2023 - 12/2002
15	Anaplastic Thyroid Carcinoma 10/2023 - 07/2008
9	medullary Thyroid cancer 12/2022 - 11/2014
7	Thyroid Nodule (Nodule, Thyroid) 10/2023 - 12/2002
7	Thyrotoxicosis 08/2022 - 12/2002
6	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2005
5	Hypoparathyroidism 11/2022 - 04/2006
5	Postoperative Pain 01/2020 - 06/2010
4	Thyroiditis 09/2023 - 01/2022
4	Hypertension (High Blood Pressure) 01/2019 - 01/2015
4	Diarrhea 01/2019 - 01/2015
4	Fatigue 01/2019 - 01/2015
3	Goiter 01/2024 - 12/2013
3	Adenoma (Adenomas) 08/2023 - 10/2017
3	Hypocalcemia 01/2023 - 12/2013
3	Nausea 01/2019 - 11/2016
3	Exanthema (Rash) 01/2019 - 01/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 03/2017 - 12/2013
2	COVID-19 02/2024 - 01/2023
2	Follicular Adenocarcinoma 10/2023 - 08/2023
2	Hyperparathyroidism 01/2023 - 01/2017
2	Pheochromocytoma 12/2022 - 12/2021
2	Paraganglioma (Paragangliomas) 12/2022 - 12/2021
2	Heart Diseases (Heart Disease) 08/2022 - 11/2007
2	Cicatrix (Scar) 06/2021 - 01/2021
2	Lymphatic Metastasis 08/2020 - 10/2007
2	Hypothyroidism 01/2020 - 05/2017
2	Folliculitis (Sycosis) 01/2019 - 11/2016
2	Sarcoma (Soft Tissue Sarcoma) 05/2018 - 03/2015
2	Hematoma 01/2018 - 10/2017
2	Carcinogenesis 10/2017 - 02/2004
2	Hemorrhage 10/2017 - 05/2005
2	Hepatocellular Carcinoma (Hepatoma) 03/2017 - 12/2013
2	Multiple Endocrine Neoplasia Type 2a (MEN 2) 06/2015 - 12/2002
2	Multiple Endocrine Neoplasia Type 2b (MEN 3) 06/2015 - 11/2014
2	Primary Hyperparathyroidism 08/2013 - 12/2004
2	Pain (Aches) 06/2012 - 01/2009
1	Overweight 04/2024
1	Obesity 11/2023
1	Sclerosis 12/2022

Drug/Important Bio-Agent (IBA)

7	Amiodarone (Amiodarona)FDA LinkGeneric 08/2022 - 12/2002
7	Antineoplastic Agents (Antineoplastics)IBA 05/2018 - 11/2014
6	Tyrosine Kinase InhibitorsIBA 01/2019 - 04/2014
6	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 04/2014
5	RacivirIBA 04/2024 - 01/2015
5	prolinedithiocarbamate (PDTC)IBA 10/2023 - 06/2018
5	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020 - 12/2002
5	vandetanib (ZD6474)IBA 01/2019 - 01/2015
4	CalciumIBA 01/2023 - 08/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
4	lenvatinibIBA 01/2019 - 01/2018
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2018 - 04/2014
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 12/2013
4	Sorafenib (BAY 43-9006)FDA Link 03/2017 - 12/2013
4	pyrimidineIBA 07/2016 - 04/2014
4	ErbB Receptors (EGF Receptor)IBA 07/2016 - 04/2014
3	selpercatinibIBA 12/2022 - 01/2022
3	Capsules (Microcapsules)IBA 01/2021 - 11/2007
3	Thyroglobulin FDA Link 08/2020 - 01/2018
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2019 - 09/2015
3	IodineIBA 01/2019 - 01/2015
3	ThiazolidinedionesIBA 01/2018 - 09/2008
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2017 - 12/2013
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 12/2022 - 12/2021
2	CatecholaminesIBA 12/2022 - 12/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2014
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2020 - 12/2002
2	Messenger RNA (mRNA)IBA 01/2019 - 02/2004
2	Carcinoembryonic AntigenIBA 01/2019 - 09/2015
2	MicroRNAs (MicroRNA)IBA 01/2019 - 10/2017
2	TabletsIBA 10/2018 - 05/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2018 - 04/2014
2	LigandsIBA 01/2018 - 01/2012
2	Hemostatics (Antihemorrhagics)IBA 10/2017 - 12/2013
2	fms-Like Tyrosine Kinase 3IBA 03/2017 - 12/2013
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 03/2015 - 12/2013
2	Galectin 3 (LGALS3)IBA 05/2010 - 10/2007
2	Iopanoic Acid (Telepaque)FDA Link 11/2007 - 12/2002
1	Heavy MetalsIBA 01/2023
1	AlbuminsIBA 01/2023
1	APTIBA 01/2023
1	Parathyroid Hormone (Parathormone)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	pralsetinibIBA 01/2022
1	3-Iodobenzylguanidine (Iobenguane)IBA 12/2021
1	Thyroid HormonesIBA 01/2020

Therapy/Procedure

34	Thyroidectomy 04/2024 - 12/2002
21	Therapeutics 11/2023 - 02/2009
8	Operative Time 09/2023 - 01/2009
4	Length of Stay 11/2023 - 12/2013
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 07/2008
2	Operative Surgical Procedures 02/2024 - 01/2021
2	Parathyroidectomy 01/2020 - 12/2004
2	Drug Therapy (Chemotherapy) 09/2008 - 07/2008
2	Radiotherapy 09/2008 - 07/2008
1	Treatment Delay 01/2023
1	General Anesthesia 08/2022
1	Autologous Transplantation 01/2022